NovoCure Ltd. (NVCR)
16.64
-0.60
(-3.48%)
USD |
NASDAQ |
Jun 10, 16:00
16.64
0.00 (0.00%)
After-Hours: 20:00
NovoCure Total Assets (Quarterly) : 787.93M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 787.93M |
| December 31, 2025 | 804.33M |
| September 30, 2025 | 1.361B |
| June 30, 2025 | 1.246B |
| March 31, 2025 | 1.249B |
| December 31, 2024 | 1.241B |
| September 30, 2024 | 1.222B |
| June 30, 2024 | 1.212B |
| March 31, 2024 | 1.121B |
| December 31, 2023 | 1.146B |
| September 30, 2023 | 1.146B |
| June 30, 2023 | 1.159B |
| March 31, 2023 | 1.174B |
| December 31, 2022 | 1.192B |
| September 30, 2022 | 1.174B |
| June 30, 2022 | 1.163B |
| March 31, 2022 | 1.150B |
| December 31, 2021 | 1.139B |
| September 30, 2021 | 1.120B |
| June 30, 2021 | 1.097B |
| March 31, 2021 | 1.068B |
| December 31, 2020 | 1.052B |
| September 30, 2020 | 431.05M |
| Date | Value |
|---|---|
| June 30, 2020 | 528.94M |
| March 31, 2020 | 502.45M |
| December 31, 2019 | 479.45M |
| September 30, 2019 | 443.86M |
| June 30, 2019 | 406.19M |
| March 31, 2019 | 370.26M |
| December 31, 2018 | 339.79M |
| September 30, 2018 | 315.51M |
| June 30, 2018 | 309.88M |
| March 31, 2018 | 303.48M |
| December 31, 2017 | 265.30M |
| September 30, 2017 | 262.28M |
| June 30, 2017 | 257.04M |
| March 31, 2017 | 264.63M |
| December 31, 2016 | 282.08M |
| September 30, 2016 | 291.09M |
| June 30, 2016 | 250.52M |
| March 31, 2016 | 279.02M |
| December 31, 2015 | 307.34M |
| September 30, 2015 | 173.78M |
| June 30, 2015 | 192.77M |
| March 31, 2015 | 118.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Smith & Nephew plc | -- |
| LivaNova Plc | 2.516B |
| Orchestra Biomed Holdings, Inc. | 100.66M |
| Accuray, Inc. | 447.60M |
| AstraZeneca PLC | 114.02B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 457.21M |
| Shareholders Equity (Quarterly) | 330.72M |
| Debt to Equity Ratio | 0.7104 |
| Current Ratio | 2.903 |
| Net Debt Paydown Yield | 7.10% |